EE200200611A - Antihüpertensiivsed ained ja kasutamine - Google Patents

Antihüpertensiivsed ained ja kasutamine

Info

Publication number
EE200200611A
EE200200611A EEP200200611A EEP200200611A EE200200611A EE 200200611 A EE200200611 A EE 200200611A EE P200200611 A EEP200200611 A EE P200200611A EE P200200611 A EEP200200611 A EE P200200611A EE 200200611 A EE200200611 A EE 200200611A
Authority
EE
Estonia
Prior art keywords
antihypertensive agents
antihypertensive
agents
Prior art date
Application number
EEP200200611A
Other languages
English (en)
Estonian (et)
Inventor
Jeffrey Auerbach Bruce
Diane Hitchcock Karen
John Ryan Michael
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE200200611A publication Critical patent/EE200200611A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200611A 2000-04-26 2001-03-22 Antihüpertensiivsed ained ja kasutamine EE200200611A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19985500P 2000-04-26 2000-04-26
US24228000P 2000-10-20 2000-10-20
PCT/US2001/009088 WO2001080847A2 (en) 2000-04-26 2001-03-22 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use

Publications (1)

Publication Number Publication Date
EE200200611A true EE200200611A (et) 2004-06-15

Family

ID=26895229

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200611A EE200200611A (et) 2000-04-26 2001-03-22 Antihüpertensiivsed ained ja kasutamine

Country Status (34)

Country Link
EP (1) EP1280522B1 (es)
JP (1) JP2003531170A (es)
KR (1) KR20020091245A (es)
CN (1) CN1426299A (es)
AP (1) AP2002002665A0 (es)
AR (1) AR031104A1 (es)
AT (1) ATE283691T1 (es)
AU (1) AU2001247658A1 (es)
BG (1) BG107264A (es)
BR (1) BR0110234A (es)
CA (1) CA2405559A1 (es)
CZ (1) CZ20023459A3 (es)
DE (1) DE60107559T2 (es)
DO (1) DOP2001000150A (es)
EA (1) EA005245B1 (es)
EE (1) EE200200611A (es)
ES (1) ES2231470T3 (es)
HR (1) HRP20020936A2 (es)
HU (1) HUP0300403A3 (es)
IL (1) IL152474A0 (es)
IS (1) IS6570A (es)
MA (1) MA26894A1 (es)
MX (1) MXPA02009662A (es)
NO (1) NO20025135L (es)
NZ (1) NZ521713A (es)
OA (1) OA12252A (es)
PA (1) PA8516001A1 (es)
PE (1) PE20011308A1 (es)
PL (1) PL357906A1 (es)
PT (1) PT1280522E (es)
SK (1) SK15132002A3 (es)
SV (1) SV2002000367A (es)
TN (1) TNSN01061A1 (es)
WO (1) WO2001080847A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
US8278310B2 (en) * 2007-06-21 2012-10-02 Actimis Pharmaceuticals, Inc. Amine salts of a CRTH2 antagonist
DE102008026033B4 (de) * 2008-05-30 2017-08-24 Voith Patent Gmbh Antriebsstrang mit einer hydrodynamischen Maschine
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
DE60107559D1 (de) 2005-01-05
MXPA02009662A (es) 2003-03-10
NZ521713A (en) 2004-09-24
ES2231470T3 (es) 2005-05-16
PE20011308A1 (es) 2002-01-18
DOP2001000150A (es) 2002-08-15
ATE283691T1 (de) 2004-12-15
CN1426299A (zh) 2003-06-25
IS6570A (is) 2002-09-27
AU2001247658A1 (en) 2001-11-07
MA26894A1 (fr) 2004-12-20
BR0110234A (pt) 2003-03-05
PT1280522E (pt) 2005-02-28
WO2001080847A3 (en) 2002-07-18
JP2003531170A (ja) 2003-10-21
OA12252A (en) 2006-05-11
BG107264A (en) 2003-07-31
PA8516001A1 (es) 2002-09-17
SV2002000367A (es) 2002-08-26
CA2405559A1 (en) 2001-11-01
EA200200953A1 (ru) 2003-04-24
AP2002002665A0 (en) 2002-12-31
DE60107559T2 (de) 2005-04-14
NO20025135D0 (no) 2002-10-25
EP1280522A2 (en) 2003-02-05
TNSN01061A1 (en) 2005-11-10
NO20025135L (no) 2002-11-27
PL357906A1 (en) 2004-08-09
EA005245B1 (ru) 2004-12-30
HRP20020936A2 (en) 2004-12-31
AR031104A1 (es) 2003-09-10
EP1280522B1 (en) 2004-12-01
SK15132002A3 (sk) 2003-08-05
KR20020091245A (ko) 2002-12-05
HUP0300403A2 (hu) 2003-06-28
WO2001080847A2 (en) 2001-11-01
HUP0300403A3 (en) 2005-03-29
IL152474A0 (en) 2003-05-29
CZ20023459A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
DE60142978D1 (de) Chirurgisches zugangsgerät und -verfahren
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
NO20022334L (no) Ny sammensetning og anvendelse
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
NO20023616L (no) Ny anvendelse
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
NO20032753D0 (no) Forbindelse og anvendelse derav
ID26130A (id) Penyempurnaan-penyempurnaan dalam alat pengantar obat
BRPI0208558A2 (pt) preparado de combinação de estrogênio-gestagênio e uso
EE200300247A (et) Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
ID23083A (id) Popok sekali pakai
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
FI20000818A0 (fi) Dermatologinen käyttö ja valmiste
DE50112472D1 (de) Abstreifer und Gutförderer
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
EE05084B1 (et) N-(heterotskll)benseen- v?i -pridiinsulfoonamiidid kui tromboosi- ja hbimisvastased ained
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate